Filter posts

Webinar Today: Comparative Effectiveness Research

As we continue to see new strides in biopharmaceutical innovation, there is increasing value in …

My Path From the BioGENEius Challenge to the White House Science Fair

My name is Natalie Ng, winner of the 2013 International BioGENEius Challenge, and I am …

Blue Ribbon Study Panel Examines Surveillance and Detection Issues in Biodefense

The Blue Ribbon Study Panel on Biodefense held the third of four meetings on Thursday, …

Celebrating the Biomedical Achievements on World Down Syndrome Day

Guest Post by Sara Hart Weir, MS, President, National Down Syndrome Society On March 21, we celebrate …

CDC Report: C. diff Infections Associated with 29,000 Deaths per Year in US; Vaccines Could Provide ...

Last month, the CDC released a new study on the impact of microbial super bug …

The Value of Innovation to Save and Transform Lives

Patients have greater hope for cures to today’s most complex and challenging diseases thanks to …

We Need Your Input: BIO Survey on Effective FDA-Sponsor Communication

BIO is surveying members and non-members on their interactions with the FDA during the various …

New PhRMA Report: A Decade of Innovation in Rare Diseases

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released “A Decade of Innovation in …

Getting Ready for #RDD2015 (Rare Disease Day 2015)

Rare Disease Day is just around the corner on February 28th. R&D investment into rare …

Biotech Could Miss a Multi-Billion Dollar Opportunity in Rare Disease

Drug development is expensive.  Drug development is risky.  Drug development takes a long time. The …